Zevacor
Trevor Subero is an accomplished professional in the field of business development with extensive experience in the healthcare and biosciences sectors. Currently serving as the Senior Vice President of Business Development at SOFIE Biosciences since September 2021, Trevor previously held multiple roles at SOFIE, including Vice President and Senior Director of Business Development from September 2017 to September 2021. Additionally, Trevor has been with Zevacor as Senior Director of Business Development since June 1998, and gained valuable experience in nuclear medicine at MedStar Washington Hospital Center from September 1993 to June 1998.
This person is not in any teams
This person is not in any offices
Zevacor
Zevacor Molecular and Zevacor Pharma, Inc. (fka IBA Molecular North America, Inc.) are both subsidiaries of Illinois Health and Science (IHS), a non-profit healthcare system that specializes in enhancing patient care through strategic investments in healthcare-related opportunities. The Zevacor family takes pride in its role helping fulfill IHS’s mission to enhance longevity and the quality of human life through improved patient care and outcomes. Zevacor Molecular and Zevacor Pharma develop, manufacture and distribute PET and SPECT radiopharmaceuticals and associated educational services used in nuclear medicine and molecular imaging. In addition, Zevacor Molecular is finalizing the construction of a new 70 MeV cyclotron and multiple synthesis and processing units for production and distribution of a broad range of clinical and research radioisotopes at its Noblesville, IN headquarters and Zevacor Pharma provides investigative and custom radiolabeling services to pharmaceutical, biotech, and research institutions nationwide helping them develop the next generation of molecular imaging and therapeutic products.